MICROTEC GESELLSCHAFT FUR MIKROTECHNOLOGIE MBH

Their core work

Microtec is a German SME specializing in microfabrication and microarray technology for diagnostic and biosensing applications. They manufacture miniaturized sensor platforms used in point-of-care medical diagnostics and environmental monitoring. Across their H2020 portfolio, they contributed microtechnology components to projects detecting sepsis biomarkers, disease-related microRNA, and waterborne pathogens like Legionella. Their core value lies in translating laboratory microarray concepts into portable, integrated detection devices.

What they specialise in

How they've shifted over time

All three of Microtec's H2020 projects started in 2015 and ran through 2018, so there is no observable shift in focus over time. Their participation represents a single concentrated period of activity in biosensing and diagnostic microtechnology. Without projects before or after this window, it is impossible to identify a directional trend from H2020 data alone.

Their H2020 activity was concentrated in 2015-2018 with no later projects, so future direction is unclear from this data — they may have shifted to commercial exploitation or other funding programs.

How they like to work

Microtec operates exclusively as a participant, never leading consortia — consistent with the role of a specialist component supplier embedded in larger research teams. With 22 unique partners across just 3 projects, they work in medium-to-large consortia (averaging ~8 partners per project) and appear comfortable integrating into diverse international teams. Their consistent participant role suggests they are sought after for specific microfabrication capabilities rather than project management.

Microtec has collaborated with 22 unique partners across 10 countries through their 3 projects, indicating broad European reach for a small company. Their network spans multiple countries, likely including key biotech and diagnostics hubs across Western and Southern Europe.

What sets them apart

Microtec occupies a niche as a microfabrication SME that bridges the gap between laboratory biosensor research and portable device manufacturing. Their involvement in three parallel biosensing projects — spanning medical diagnostics and environmental monitoring — shows they can adapt their core microarray fabrication skills to different detection targets. For consortium builders, they offer a rare combination: an industry partner with hands-on manufacturing capability for miniaturized sensor platforms, based in Germany's Ruhr industrial region.

Highlights from their portfolio

• RAIS
  Largest funding share (EUR 298,750) and addresses the critical clinical need of rapid sepsis detection using a scalable, label-free microarray platform.
• CYTO-WATER
  Extends Microtec's biosensing expertise beyond healthcare into industrial water safety, demonstrating cross-sector versatility in pathogen detection.
• SAPHELY
  Focused on microRNA-based early disease diagnosis using photonic biosensing, representing the most technically advanced sensing approach in their portfolio.